Skip to content
Faron, etusivu
Careers
For Patients
Contact Information
Search for:
LANGUAGE
English
Suomi
About
Management
Board of directors
Scientific Advisory Board
Sustainability
Pipeline
Our science
Clinical trials
Drug candidates
Investors
Faron as an investment
Strategy
Faron’s business
Market overview
Key financials
Analysts
Analysis
Outlook
Share and shareholders
Share information
Share monitor
Shareholders
Management ownership and transactions
Option plans and Warrants
Public offering 2024
Rights Offering 2026
AIM rule 26
Governance
Advisors
Articles of association
Auditor
Board committees
General Meeting
Insider management
Remuneration
Risk management and internal control
Reports and presentations
Investor relations
Disclosure policy
Investor calendar
Contact Information
Newsroom
Releases and announcements
Reports and presentations
About
Management
Board of directors
Scientific Advisory Board
Sustainability
Pipeline
Our science
Clinical trials
Drug candidates
Investors
Faron as an investment
Strategy
Faron’s business
Market overview
Key financials
Analysts
Analysis
Outlook
Share and shareholders
Share information
Share monitor
Shareholders
Management ownership and transactions
Option plans and Warrants
Public offering 2024
Rights Offering 2026
AIM rule 26
Governance
Advisors
Articles of association
Auditor
Board committees
General Meeting
Insider management
Remuneration
Risk management and internal control
Reports and presentations
Investor relations
Disclosure policy
Investor calendar
Contact Information
Newsroom
Releases and announcements
Reports and presentations
Careers
For Patients
Contact Information
Search for:
LANGUAGE
English
Suomi
releases and announcements
Category
All
Company announcements
Press releases
Managers' transactions
Flagging notifications
Year
All
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
24.03.2023
Results of AGM
Regulatory
22.03.2023
Positive FDA Feedback to Progress Bexmarilimab
Regulatory
03.03.2023
Notice of Faron Pharmaceuticals Ltd’s AGM
Regulatory
03.03.2023
Faron´s Annual Report 2022 Published
Regulatory
03.03.2023
Financial Statement January 1 to December 31 2022
Regulatory
06.02.2023
Update to Faron’s Financial Calendar for 2023
Regulatory
06.02.2023
Notice of 2022 Full-Year Results and Annual Report
01.02.2023
Holding(s) in Company
Shareholder announcement
Regulatory
27.01.2023
Holding(s) in Company
Shareholder announcement
Regulatory
27.01.2023
Results of Placing
Regulatory
Previous
Next
Back to top
